587 related articles for article (PubMed ID: 33069253)
1. Evaluation of OAR dose sparing and plan robustness of beam-specific PTV in lung cancer IMRT treatment.
Chang Y; Xiao F; Quan H; Yang Z
Radiat Oncol; 2020 Oct; 15(1):241. PubMed ID: 33069253
[TBL] [Abstract][Full Text] [Related]
2. Robust optimization in lung treatment plans accounting for geometric uncertainty.
Zhang X; Rong Y; Morrill S; Fang J; Narayanasamy G; Galhardo E; Maraboyina S; Croft C; Xia F; Penagaricano J
J Appl Clin Med Phys; 2018 May; 19(3):19-26. PubMed ID: 29524301
[TBL] [Abstract][Full Text] [Related]
3. Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer.
Outaggarts Z; Wegener D; Berger B; Zips D; Paulsen F; Bleif M; Thorwarth D; Alber M; Dohm O; Müller AC
Acta Oncol; 2020 Aug; 59(8):911-917. PubMed ID: 32436467
[No Abstract] [Full Text] [Related]
4. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
Liu W; Frank SJ; Li X; Li Y; Zhu RX; Mohan R
Med Phys; 2013 Feb; 40(2):021709. PubMed ID: 23387732
[TBL] [Abstract][Full Text] [Related]
5. A beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties.
Park PC; Zhu XR; Lee AK; Sahoo N; Melancon AD; Zhang L; Dong L
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e329-36. PubMed ID: 21703781
[TBL] [Abstract][Full Text] [Related]
6. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
Stützer K; Lin A; Kirk M; Lin L
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers.
Liu W; Frank SJ; Li X; Li Y; Park PC; Dong L; Ronald Zhu X; Mohan R
Med Phys; 2013 May; 40(5):051711. PubMed ID: 23635259
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
9. Impact of dose calculation accuracy during optimization on lung IMRT plan quality.
Li Y; Rodrigues A; Li T; Yuan L; Yin FF; Wu QJ
J Appl Clin Med Phys; 2015 Jan; 16(1):5137. PubMed ID: 25679172
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of robust optimization against geometric uncertainties in TomoHelical planning for prostate cancer.
Yagihashi T; Inoue K; Nagata H; Yamanaka M; Yamano A; Suzuki S; Yamakabe W; Sato N; Omura M; Inoue T
J Appl Clin Med Phys; 2023 Apr; 24(4):e13881. PubMed ID: 36576418
[TBL] [Abstract][Full Text] [Related]
12. An Analysis of Plan Robustness for Esophageal Tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton Planning.
Warren S; Partridge M; Bolsi A; Lomax AJ; Hurt C; Crosby T; Hawkins MA
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):199-207. PubMed ID: 27084641
[TBL] [Abstract][Full Text] [Related]
13. An IMRT planning technique for treating whole breast or chest wall with regional lymph nodes on Halcyon and Ethos.
Rayn K; Clark R; Hoxha K; Magliari A; Neylon J; Xiang MH; O'Connell DP
J Appl Clin Med Phys; 2024 May; 25(5):e14295. PubMed ID: 38335253
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of dosimetric margins in prostate IMRT treatment plans.
Gordon JJ; Siebers JV
Med Phys; 2008 Feb; 35(2):569-75. PubMed ID: 18383678
[TBL] [Abstract][Full Text] [Related]
15. Development of a Monte Carlo based robustness calculation and evaluation tool.
Loebner HA; Volken W; Mueller S; Bertholet J; Mackeprang PH; Guyer G; Aebersold DM; Stampanoni MFM; Manser P; Fix MK
Med Phys; 2022 Jul; 49(7):4780-4793. PubMed ID: 35451087
[TBL] [Abstract][Full Text] [Related]
16. Normal lung sparing Tomotherapy technique in stage III lung cancer.
Hong CS; Ju SG; Ahn YC; Yoo GS; Noh JM; Oh D; Chung K; Pyo H; Jo K
Radiat Oncol; 2017 Nov; 12(1):167. PubMed ID: 29110732
[TBL] [Abstract][Full Text] [Related]
17. Intensity modulated radiotherapy of non-small-cell lung cancer incorporating SPECT ventilation imaging.
Munawar I; Yaremko BP; Craig J; Oliver M; Gaede S; Rodrigues G; Yu E; Reid RH; Leung E; Urbain JL; Chen J; Wong E
Med Phys; 2010 Apr; 37(4):1863-72. PubMed ID: 20443508
[TBL] [Abstract][Full Text] [Related]
18. Is a clinical target volume (CTV) necessary for locally advanced non-small cell lung cancer treated with intensity-modulated radiotherapy? -a dosimetric evaluation of three different treatment plans.
Xia F; Zhou L; Yang X; Chu L; Zhang X; Chu J; Hu W; Zhu Z
J Thorac Dis; 2017 Dec; 9(12):5194-5202. PubMed ID: 29312726
[TBL] [Abstract][Full Text] [Related]
19. A dosimetric comparison of intensity-modulated radiotherapy versus rapid arc in gynecological malignancies: Dose beyond planning target volume, precisely 5Gy volume.
Sidhu MS; Singh K; Sood S; Aggarwal R
J Cancer Res Ther; 2023; 19(5):1267-1271. PubMed ID: 37787294
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
